| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Nov 16, 2022 | Nov 18, 2022 | Chemomab Therapeutics Ltd. | Director | Sell | 27.5 | -2,409 | -19.41% | ✗ | $4.8K |
| May 18, 2022 | May 19, 2022 | Chemomab Therapeutics Ltd. | Director | Buy | 90.0 | +2,000 | 19.21% | ✗ | $6.4K |
| Mar 14, 2022 | Mar 15, 2022 | Chemomab Therapeutics Ltd. | Director | Buy | 91.3 | +6,000 | 136.09% | ✗ | $26.1K |
| Dec 6, 2021 | Dec 8, 2021 | Chemomab Therapeutics Ltd. | Director | Buy | 91.3 | +2,000 | 83.02% | ✗ | $14.9K |
| Mar 16, 2021 | Mar 26, 2021 | Chemomab Therapeutics Ltd. | Director | Buy | 95.0 | +2,409 | 100.00% | ✗ | $100K |